期刊文献+

急诊监护室应用左西孟旦治疗老年重症顽固性心力衰竭的疗效研究 被引量:7

Effect of intravenous levosimendan in the treatment of 35 patients with acute intractable heart failure in the EICU
下载PDF
导出
摘要 目的评价左西孟旦(Levosimendan Injection)在急诊监护室(EICU)治疗老年顽固性心力衰竭的临床研究,探讨其疗效及安全性。方法将68例重症老年顽固性心力衰竭患者随机分为治疗组和对照组。治疗组(35例)给予左西孟旦注射液治疗,对照组(33例)予以米力农治疗。比较治疗前后两组全身状况、呼吸困难程度、心功能改善程度、B型脑利钠肽(BNP)、心脏指数(CI)、左室射血分数(LVEF)和E/A等指标,定期检测血压、心率、肝肾功能及血电解质等,并记录药物相关不良反应。结果治疗72 h后,治疗组呼吸困难程度和临床状况、心功能明显改善(显效)27例,有效4例,总有效率88.6%;对照组分别为显效15例、有效6例,总有效率63.6%。两组心功能总有效率比较P<0.01。用药1周后BNP明显降低,LVEF、CI亦有明显升高(P<0.05),未发生明显药物不良反应。结论左西孟旦在EICU治疗老年重症顽固性心衰患者可迅速明显改善患者的心功能、提高射血分数等,该药疗效显著,安全可靠,值得推广应用。 Objective:To evaluate the clinical effect of levosimendan on intractable heart failure in patients in emergen-cy intensive care unit( EICU). Methods:Sixty-eight patients with refractory heart failure were randomly divided into treat-ment group and control group. The treatment group(35 cases)were treated with levosimendan injection therapy,the con-trol group(33 cases)with milinone injection treatment. Systemic treatment status,difficulty breathing,improvement of heart function,B type natriuretic peptide( BNP)belly,cardiac index( CI),left ventricular ejection fraction( LVEF)and E/A were compared before and after the treatment,heart rate,blood pressure,liver and kidney function and blood electro-lytes were detected regularly,and the adverse reaction of drugs was recorded. Results:After 72 hours treatment in the treatment group,degree of dyspnea and clinical status improved,heart function( effect)in 27 cases,4 cases was effective, and the total effective rate was 88. 6%;15 cases of the control group were marked,6 cases was effective,and the total effi-ciency was 63. 6%. The total efficiency of cardiac function in the two groups was P〈0. 01. After one week,the BNP de-creased significantly,but LVEF and CI significantly increased(P〈0. 05),and there was no obvious adverse drug reac-tion. Conclusion:Levosimendan can rapidly improve heart function of patients with intractable HF,improve the ejection fraction in EICU application,the drug effect is significant,safe and reliable,which is worthy of popularization and applica-tion.
作者 刘明 张红欣
出处 《泰山医学院学报》 CAS 2015年第1期7-9,共3页 Journal of Taishan Medical College
基金 山东省医药卫生科技发展计划项目(2014WS0195) 泰安市科研计划项目(20103020) 山东省自然科学基金项目(ZR2009CM028) 山东省卫生厅项目(2009HZ098) 山东省高校科技计划项目(J09LF69)
关键词 左西孟旦 EICU 顽固性充血性心力衰竭 levosimendan EICU intractable heart failure validation studies
  • 相关文献

参考文献10

  • 1Dec GW. Acute decompensated heart failure : the shirking role ofinotropic therapy[ J]. J Am Coll Cordial, 2005,46( 1) :65 -67.
  • 2Massie BM,Shah NB. Evolving trends kin the epidemiologic factorsof heart failure : rational for preventive stratagies and comprehen-sive disease management[ J]. Am Heart J,1997,133 :703 -712.
  • 3Kersten JR, Montgomery MW.Pagel PS, et al. Levosi-mendan. aNew positive inotropic drug, decreases myocardial infarct size viaactivation of KATP channels[ J]. Anesth Analg, 2000,90(1) :5 -11.
  • 4Sonntag S, Sundbei^ S, Lehtonen I, et al. The calcium sensitizerlevosimendan improves the function of stunned myocardi, um alterpercutaneous transluminal coronary angioplasty in acute myocardialischemia[J]. J Am Cbll Ckidio’2010’43(12)2177 -2182.
  • 5Papp Z, C sapo K, Pollesellop P, et al. Pharmacological mecha-nisms Contributing to the clinical efficacy of levosimendan [ J ].Cardiovasc Drug Rev,2009 ,12(1 ) :71 -98.
  • 6Kaheinen P,Pollesello P,Levijoki J,et al. Effects ol levosimendanand milrinone on oxygen consumption in isolated guinea pigheart[J]. J Ckrdiovaac Pharmacol ,2010,43(4) :555 -561.
  • 7Yokoshi H, Katsube Y, Suangawa M, et al. Levosimendan, a no-vel Ca2+ sensitizer, activates the glibenclamidesensitive K + chan-nel in rat arterial myocytesf J]. Eur J Pharmacol, 1997, 333(2 -3) :249-259.
  • 8Lee SC, Stevens TL, Sandberg SM, et al. The potential of brainnapeptide as a biomarker for New York Heart Association class dur-ing the outpatient treatment of liearl failure [ J ]. J Card Fail,2002,8(3) :149 -154.
  • 9Nieminen MS. Levosimendan compared witli dobutamine in lowoutput[ J]. Minerva Anestesiol,2003,69(4) :258 - 263.
  • 10Kersten JR, Montgomery MW,Pagel PS, et al. Levosimendan,a new positiveinotropic drug, decreases myocardial infarct, sizevia activation of KATP channels[ J]. Anesth Analg,2011,2:5 -11.

同被引文献43

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部